These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 19608783

  • 21. [Statin myopathy--rarity or reality?].
    Pella D.
    Vnitr Lek; 2010 Sep; 56(9 Suppl):972-6. PubMed ID: 21137170
    [Abstract] [Full Text] [Related]

  • 22. Statin myotoxicity: a review of genetic susceptibility factors.
    Needham M, Mastaglia FL.
    Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465
    [Abstract] [Full Text] [Related]

  • 23. Drug-induced myopathies.
    Le Quintrec JS, Le Quintrec JL.
    Baillieres Clin Rheumatol; 1991 Apr; 5(1):21-38. PubMed ID: 2070426
    [Abstract] [Full Text] [Related]

  • 24. Clinical and pathological aspects of toxic myopathies.
    Le Quang M, Solé G, Martin-Négrier ML, Mathis S.
    J Neurol; 2024 Sep; 271(9):5722-5745. PubMed ID: 38907023
    [Abstract] [Full Text] [Related]

  • 25. Toxic and Endocrine Myopathies.
    Katzberg HD, Kassardjian CD.
    Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1815-1828. PubMed ID: 27922495
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The spectrum of statin myopathy.
    Mohassel P, Mammen AL.
    Curr Opin Rheumatol; 2013 Nov; 25(6):747-52. PubMed ID: 24061077
    [Abstract] [Full Text] [Related]

  • 29. Drug-induced myopathies.
    Argov Z.
    Curr Opin Neurol; 2000 Oct; 13(5):541-5. PubMed ID: 11073360
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
    Mohassel P, Mammen AL.
    Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Statins and skeletal muscles toxicity: from clinical trials to everyday practice.
    Norata GD, Tibolla G, Catapano AL.
    Pharmacol Res; 2014 Oct; 88():107-13. PubMed ID: 24835295
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Statin-induced muscle toxicity and susceptibility to malignant hyperthermia and other muscle diseases: a population-based case-control study including 1st and 2nd degree relatives.
    Hedenmalm K, Granberg AG, Dahl ML.
    Eur J Clin Pharmacol; 2015 Jan; 71(1):117-24. PubMed ID: 25367069
    [Abstract] [Full Text] [Related]

  • 38. [Indirect and mixed mechanisms of action in toxic myopathies].
    Khelfi A, Azzouz M, Abtroun R, Reggabi M, Alamir B.
    Ann Pharm Fr; 2018 Jul; 76(4):273-285. PubMed ID: 29803327
    [Abstract] [Full Text] [Related]

  • 39. Statin myopathy: a review of recent progress.
    Mammen AL, Amato AA.
    Curr Opin Rheumatol; 2010 Nov; 22(6):644-50. PubMed ID: 20827205
    [Abstract] [Full Text] [Related]

  • 40. [Muscle-related adverse effects of statins].
    Pohjola-Sintonen S, Julkunen H.
    Duodecim; 2014 Nov; 130(16):1622-7. PubMed ID: 25269368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.